We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.1B
AUM Growth
+$81.4M
Cap. Flow
+$15.7M
Cap. Flow %
1.43%
Top 10 Hldgs %
30.75%
Holding
185
New
8
Increased
66
Reduced
44
Closed
1

Top Sells

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$1.37M
2
WPP icon
WPP
WPP
+$756K
3
DOX icon
Amdocs
DOX
+$439K
4
WLY icon
John Wiley & Sons Class A
WLY
+$421K
5
XOM icon
ExxonMobil
XOM
+$390K

Sector Composition

Rank Sector Weight
1 Technology 26.65%
2 Healthcare 17.66%
3 Financials 11.62%
4 Consumer Staples 10.27%
5 Industrials 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
76
Colgate-Palmolive
CL
$74.2B
$1.72M 0.16%
25,006
ADP icon
77
Automatic Data Processing
ADP
$106B
$1.72M 0.16%
10,063
VRTX icon
78
Vertex Pharmaceuticals
VRTX
$124B
$1.6M 0.15%
7,292
+285
+4% +$57.7K
HON icon
79
Honeywell
HON
$78.3B
$1.59M 0.14%
9,512
SGEN
80
DELISTED
Seagen Inc. Common Stock
SGEN
$1.58M 0.14%
13,810
+575
+4% +$61K
NTR icon
81
Nutrien
NTR
$33.3B
$1.49M 0.14%
31,026
+66
+0.2% +$3.19K
ABT icon
82
Abbott
ABT
$187B
$1.47M 0.13%
16,952
COST icon
83
Costco
COST
$429B
$1.41M 0.13%
4,799
GOOGL icon
84
Alphabet (Google) Class A
GOOGL
$4.08T
$1.24M 0.11%
18,580
T icon
85
AT&T
T
$169B
$1.21M 0.11%
40,900
-4,525
-10% -$131K
BMY icon
86
Bristol-Myers Squibb
BMY
$130B
$1.14M 0.1%
17,768
+2,544
+17% +$146K
KMB icon
87
Kimberly-Clark
KMB
$37.5B
$1.11M 0.1%
8,073
GE icon
88
GE Aerospace
GE
$377B
$1.11M 0.1%
19,931
-128
-0.6% -$6.61K
GOOG icon
89
Alphabet (Google) Class C
GOOG
$4.07T
$1.1M 0.1%
16,440
FAST icon
90
Fastenal
FAST
$55.2B
$1.09M 0.1%
59,140
EMR icon
91
Emerson Electric
EMR
$85B
$1.09M 0.1%
14,273
HD icon
92
Home Depot
HD
$343B
$1.09M 0.1%
4,975
NBIX icon
93
Neurocrine Biosciences
NBIX
$18.4B
$1.08M 0.1%
10,006
+540
+6% +$56.5K
RTX icon
94
RTX Corp
RTX
$295B
$1.04M 0.09%
11,042
-645
-6% -$58.5K
IONS icon
95
Ionis Pharmaceuticals
IONS
$9.14B
$1.01M 0.09%
16,676
+855
+5% +$50.9K
BP icon
96
BP
BP
$107B
$931K 0.08%
24,675
-28
-0.1% -$1.06K
INCY icon
97
Incyte
INCY
$26B
$928K 0.08%
10,625
+885
+9% +$75.6K
ISRG icon
98
Intuitive Surgical
ISRG
$130B
$914K 0.08%
4,638
BDX icon
99
Becton Dickinson
BDX
$45.8B
$900K 0.08%
3,393
-328
-9% -$81.8K
PM icon
100
Philip Morris
PM
$312B
$899K 0.08%
10,561
-147
-1% -$12.1K

Similar funds

Grandfield & Dodd's Q4 2019 Portfolio in Review

As of Q4 2019, Grandfield & Dodd held 185 positions worth $1.1B, up 8% from $1.02B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 4.9%. Grandfield & Dodd opened 8 new positions and exited 1, leaving the 185-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q4 2019 buy was Nektar Therapeutics: 1,048 shares worth $339K.
  • Grandfield & Dodd added most to Walt Disney in Q4 2019, an estimated $2.41M increase.
  • Grandfield & Dodd's biggest Q4 2019 reduction was eBay, cutting an estimated $1.37M.
  • Grandfield & Dodd fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $233K.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $1.1B portfolio in Q4 2019.
  • Grandfield & Dodd opened 8 new positions and closed 1 in Q4 2019.
  • Grandfield & Dodd's portfolio value rose 8% quarter-over-quarter to $1.1B.

Based on Grandfield & Dodd's 13F filing for Q4 2019, filed 7 Feb 2020.